Canada Life
LRMR icon

Canada Life’s Larimar Therapeutics LRMR Stock Holding History

Canada Life’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-146
Closed -$12K – 2517
2016
Q1 		$12K Hold
146
– – ﹤0.01% 2392
2015
Q4 		$11K Hold
146
– – ﹤0.01% 2418
2015
Q3 		$56K Hold
146
– – ﹤0.01% 2042
2015
Q2 		$60K Hold
146
– – ﹤0.01% 2128
2015
Q1 		$69K Buy
+146
New +$69.3K ﹤0.01% 1990

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Canada Life's LRMR Position: Q2 2016 in Review

Canada Life sold out of Larimar Therapeutics (LRMR) in Q2 2016, closing a stake of 146 shares — an estimated $12K sold.

Canada Life first reported a position in LRMR in Q1 2015 and held it in 5 quarters. The position peaked at $69K in Q1 2015. 73 funds tracked by Wall St. Rank hold LRMR as of Q2 2016.

  • Canada Life reported no remaining Larimar Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Canada Life sold 146 Larimar Therapeutics shares in Q2 2016, an estimated $12K.
  • Canada Life first reported a position in Larimar Therapeutics in Q1 2015 and held it in 5 quarters.
  • Canada Life's Larimar Therapeutics position peaked at $69K in Q1 2015.
  • 73 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2016.

Based on Canada Life's 13F filing for Q2 2016, filed 3 Aug 2016.